Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CML
The achievement of major molecular response (MMR, BCR::ABL1 ≤ 0.1% IS) within the first year of treatment with tyrosine kinase inhibitors (TKI) is a milestone in the therapeutic management of patients with newly diagnosed chronic myeloid leukemia (CML). We analyzed the predictive value of gene expre...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
8 May 2023
|
| In: |
Cancers
Year: 2023, Jahrgang: 15, Heft: 9, Pages: 1-17 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15092652 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers15092652 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/15/9/2652 
|
| Verfasserangaben: | Eva Christiani, Nicole Naumann, Christel Weiss, Birgit Spiess, Helga Kleiner, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saussele and Wolfgang Seifarth |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1848499310 | ||
| 003 | DE-627 | ||
| 005 | 20230706204456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230609s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers15092652 |2 doi | |
| 035 | |a (DE-627)1848499310 | ||
| 035 | |a (DE-599)KXP1848499310 | ||
| 035 | |a (OCoLC)1389528748 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Christiani, Eva |e VerfasserIn |0 (DE-588)1292499036 |0 (DE-627)1848500483 |4 aut | |
| 245 | 1 | 0 | |a Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CML |c Eva Christiani, Nicole Naumann, Christel Weiss, Birgit Spiess, Helga Kleiner, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saussele and Wolfgang Seifarth |
| 246 | 3 | 0 | |a one |
| 264 | 1 | |c 8 May 2023 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.06.2023 | ||
| 520 | |a The achievement of major molecular response (MMR, BCR::ABL1 ≤ 0.1% IS) within the first year of treatment with tyrosine kinase inhibitors (TKI) is a milestone in the therapeutic management of patients with newly diagnosed chronic myeloid leukemia (CML). We analyzed the predictive value of gene expression levels of ESPL1/Separase, PTTG1/Securin and PTTG1IP/Securin interacting protein for MMR achievement within 12 months. Relative expression levels (normalized to GUSB) of ESPL1, PTTG1 and PTTG1IP in white blood cells of patients (responders n = 46, non-responders n = 51) at the time of diagnosis were comparatively analyzed by qRT-PCR. 3D scatter plot analysis combined with a distance analysis performed with respect to a commonly calculated centroid center resulted in a trend to larger distances for non-responders compared to the responder cohort (p = 0.0187). Logistic regression and analysis of maximum likelihood estimates revealed a positive correlation of distance (cut-off) with non-achieving MMR within 12 months (p = 0.0388, odds ratio 1.479, 95%CI: 1.020 to 2.143). Thus, 10% of the tested non-responders (cut-off ≥ 5.9) could have been predicted already at the time of diagnosis. Future scoring of ESPL1, PTTG1 and PTTG1IP transcript levels may be a helpful tool in risk stratification of CML patients before initiation of TKI first-line treatment. | ||
| 650 | 4 | |a BCR::ABL1 expression | |
| 650 | 4 | |a ESPL1/Separase | |
| 650 | 4 | |a PTTG1/Securin | |
| 650 | 4 | |a PTTG1IP/Securin interacting protein | |
| 650 | 4 | |a chronic myeloid leukemia (CML) | |
| 650 | 4 | |a major molecular response (MMR) | |
| 650 | 4 | |a risk stratification at initial diagnosis | |
| 650 | 4 | |a TKI first-line treatment | |
| 700 | 1 | |a Naumann, Nicole |d 1988- |e VerfasserIn |0 (DE-588)1138951838 |0 (DE-627)896569624 |0 (DE-576)49279314X |4 aut | |
| 700 | 1 | |a Weiß, Christel |d 1958- |e VerfasserIn |0 (DE-588)123287707 |0 (DE-627)082463417 |0 (DE-576)168356104 |4 aut | |
| 700 | 1 | |a Spiess, Birgit |d 1972- |e VerfasserIn |0 (DE-588)1028287496 |0 (DE-627)730538699 |0 (DE-576)37578764X |4 aut | |
| 700 | 1 | |a Kleiner, Helga |e VerfasserIn |0 (DE-588)1075839017 |0 (DE-627)833987380 |0 (DE-576)444702644 |4 aut | |
| 700 | 1 | |a Fabarius, Alice |d 1965- |e VerfasserIn |0 (DE-588)1037001281 |0 (DE-627)751728314 |0 (DE-576)390896667 |4 aut | |
| 700 | 1 | |a Hofmann, Wolf-Karsten |d 1967- |e VerfasserIn |0 (DE-588)114154635 |0 (DE-627)691208751 |0 (DE-576)351568336 |4 aut | |
| 700 | 1 | |a Saußele, Susanne |d 1968- |e VerfasserIn |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 aut | |
| 700 | 1 | |a Seifarth, Wolfgang |d 1960- |e VerfasserIn |0 (DE-588)1042491887 |0 (DE-627)769066453 |0 (DE-576)393988899 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 15(2023), 9 vom: Mai, Artikel-ID 2652, Seite 1-17 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CML |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:9 |g month:05 |g elocationid:2652 |g pages:1-17 |g extent:17 |a Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CML |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers15092652 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/15/9/2652 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230609 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1042491887 |a Seifarth, Wolfgang |m 1042491887:Seifarth, Wolfgang |d 60000 |d 61200 |e 60000PS1042491887 |e 61200PS1042491887 |k 0/60000/ |k 1/60000/61200/ |p 9 |y j | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |e 60000PS115839860 |e 61200PS115839860 |k 0/60000/ |k 1/60000/61200/ |p 8 | ||
| 998 | |g 114154635 |a Hofmann, Wolf-Karsten |m 114154635:Hofmann, Wolf-Karsten |d 60000 |d 61200 |e 60000PH114154635 |e 61200PH114154635 |k 0/60000/ |k 1/60000/61200/ |p 7 | ||
| 998 | |g 1037001281 |a Fabarius, Alice |m 1037001281:Fabarius, Alice |d 60000 |d 61200 |e 60000PF1037001281 |e 61200PF1037001281 |k 0/60000/ |k 1/60000/61200/ |p 6 | ||
| 998 | |g 1075839017 |a Kleiner, Helga |m 1075839017:Kleiner, Helga |d 60000 |d 61200 |e 60000PK1075839017 |e 61200PK1075839017 |k 0/60000/ |k 1/60000/61200/ |p 5 | ||
| 998 | |g 1028287496 |a Spiess, Birgit |m 1028287496:Spiess, Birgit |d 60000 |d 61200 |e 60000PS1028287496 |e 61200PS1028287496 |k 0/60000/ |k 1/60000/61200/ |p 4 | ||
| 998 | |g 123287707 |a Weiß, Christel |m 123287707:Weiß, Christel |d 60000 |d 60200 |d 60250 |d 60000 |e 60000PW123287707 |e 60200PW123287707 |e 60250PW123287707 |e 60000PW123287707 |k 0/60000/ |k 1/60000/60200/ |k 2/60000/60200/60250/ |k 0/60000/ |p 3 | ||
| 998 | |g 1138951838 |a Naumann, Nicole |m 1138951838:Naumann, Nicole |d 60000 |d 61200 |e 60000PN1138951838 |e 61200PN1138951838 |k 0/60000/ |k 1/60000/61200/ |p 2 | ||
| 998 | |g 1292499036 |a Christiani, Eva |m 1292499036:Christiani, Eva |d 60000 |e 60000PC1292499036 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1848499310 |e 433087721X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CML","title_sort":"Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CML"}],"person":[{"role":"aut","family":"Christiani","given":"Eva","display":"Christiani, Eva"},{"display":"Naumann, Nicole","given":"Nicole","family":"Naumann","role":"aut"},{"family":"Weiß","display":"Weiß, Christel","given":"Christel","role":"aut"},{"role":"aut","display":"Spiess, Birgit","given":"Birgit","family":"Spiess"},{"role":"aut","given":"Helga","display":"Kleiner, Helga","family":"Kleiner"},{"family":"Fabarius","given":"Alice","display":"Fabarius, Alice","role":"aut"},{"role":"aut","display":"Hofmann, Wolf-Karsten","given":"Wolf-Karsten","family":"Hofmann"},{"family":"Saußele","given":"Susanne","display":"Saußele, Susanne","role":"aut"},{"family":"Seifarth","display":"Seifarth, Wolfgang","given":"Wolfgang","role":"aut"}],"recId":"1848499310","origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"8 May 2023"}],"name":{"displayForm":["Eva Christiani, Nicole Naumann, Christel Weiss, Birgit Spiess, Helga Kleiner, Alice Fabarius, Wolf-Karsten Hofmann, Susanne Saussele and Wolfgang Seifarth"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2009 -"],"language":["eng"],"recId":"614095670","disp":"Gene expression pattern of ESPL1, PTTG1 and PTTG1IP can potentially predict response to TKI first-line treatment of patients with newly diagnosed CMLCancers","note":["Gesehen am 27.05.2020"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2023","pages":"1-17","text":"15(2023), 9 vom: Mai, Artikel-ID 2652, Seite 1-17","volume":"15","extent":"17","issue":"9"},"id":{"zdb":["2527080-1"],"issn":["2072-6694"],"eki":["614095670"]},"title":[{"title_sort":"Cancers","title":"Cancers"}],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2009","dateIssuedDisp":"2009-","publisher":"MDPI"}],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]}}],"note":["Gesehen am 09.06.2023"],"physDesc":[{"extent":"17 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.3390/cancers15092652"],"eki":["1848499310"]}} | ||
| SRT | |a CHRISTIANIGENEEXPRES8202 | ||